All In Biotech

Free tool

FAERS Monitor: Prolia

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125320 or its brand name (Prolia, Denosumab). Reports on generic versions are filed under their own applications.

Reports

203,628

Serious

111,298

55% of reports

Hospitalization

32,053

Death reported

26,093

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use36,806
  • death20,597
  • arthralgia8,975
  • osteonecrosis of jaw8,703
  • fatigue7,855
  • pain in extremity7,063
  • pain7,019
  • back pain6,993
  • nausea5,551
  • diarrhoea5,433
  • fall5,380
  • rash4,374
  • myalgia4,246
  • asthenia4,134
  • bone pain4,071

Reports by year received

View as table
YearReports
20081
20093
2010146
20111,755
20125,568
20137,360
201411,624
201512,375
201620,402
201733,839
201833,692
201911,455
202010,399
202110,073
20229,831
202310,693
20249,318
20257,953
20267,141

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,850,531 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
osteonecrosis of jawSignal8,70355.554.1302,225
bone painSignal4,0717.67.421,917
off label useSignal36,8064.54.499,739
back painSignal6,9933.23.110,214
myalgiaSignal4,2462.62.54,179
pain in extremitySignal7,0632.52.56,363
deathSignal20,5972.52.518,961
arthralgiaSignal8,9752.32.26,268
fall5,3801.71.61,482
pain7,0191.21.2201
asthenia4,1341.11.169
fatigue7,8551.01.014
rash4,3741.01.06
diarrhoea5,4330.90.8111
nausea5,5510.70.7610

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.